ACAAI 2019

Complete Coverage

Using Electronic Health Records to Predict Mortality Post COPD Hospitalization

By

Sheila Jacobs

Publish Date May 9, 2022

For COPD, can electronic health record data predict 90-day post hospitalization mortality — and thereby serve as a risk stratification tool?

Dupilumab May Lower Exacerbation Rates in Allergic Bronchopulmonary Aspergillosis

By

Britt Gambino

Publish Date November 13, 2019

In a post hoc analysis of the LIBERTY ASTHMA QUEST study, researchers found that dupilumab may reduce exacerbations in patients with allergic bronchopulmonary aspergillosis.

Benralizumab Improved Total Nasal Symptom Score in Severe Asthma

By

Pulmonology Advisor Contributing Writer

Publish Date November 11, 2019

Among patients with severe asthma, benralizumab treatment improved nasal symptoms, which worsen with increasing baseline blood eosinophil count.

Mepolizumab Significantly Reduces Asthma Exacerbations and Associated Costs

By

Pulmonology Advisor Contributing Writer

Publish Date November 11, 2019

In a real-world setting, mepolizumab therapy significantly reduced the rate of asthma exacerbations and their related costs.

Family History of Cancer: A Significant Risk Factor for Childhood Asthma?

By

Pulmonology Advisor Contributing Writer

Publish Date November 11, 2019

Children with a family history of cancer may be more likely to develop childhood asthma.

Ragweed SLIT Tablet Improves Symptoms in Children With Ragweed Allergic Rhinitis

By

Britt Gambino

Publish Date November 11, 2019

Ragweed sublingual immunotherapy tablet improved symptoms and decreased the need for rescue medication in the largest allergy immunotherapy trial in children with ragweed allergic rhinitis with or without conjunctivitis.

High-Dose Peanut Oral Immunotherapy Safe, Effective for Peanut Allergy

By

Britt Gambino

Publish Date November 11, 2019

High-dose peanut oral immunotherapy provided similar or greater efficacy than other previously reported forms of peanut oral immunotherapy without additional safety concerns.

FeNO May Assist in Diagnosing Cough Variant Asthma in Chronic Cough

By

Brandon May

Publish Date November 10, 2019

Fractional exhaled nitric oxide values may help in the identification of cough variant asthma in patients with chronic cough.

Budesonide Oral Suspension Improves Dysphagia in Eosinophilic Esophagitis

By

Brandon May

Publish Date November 10, 2019

Budesonide oral suspension was associated with improvements in dysphagia in patients with eosinophilic esophagitis.

Mepolizumab Reduced Eosinophils, Exacerbations in Severe Eosinophilic Asthma

By

Brandon May

Publish Date November 10, 2019

Mepolizumab was associated with reductions in eosinophil levels and asthma exacerbations,as well as improvements in quality of life in uncontrolled severe eosinophilic asthma.